.

Deeper Knowledge, Faster

  • Anticipate your formulary budget
  • Obtain formulation and manufacturing information
  • Drug patents and clinical trials in dozens of countries

► See Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

AstraZeneca
Julphar
Accenture
Novartis
Cipla
US Department of Justice
Johnson and Johnson
Moodys
Merck
Colorcon

Generated: June 24, 2017

DrugPatentWatch Database Preview

ACHROMYCIN V Drug Profile

« Back to Dashboard

What is the patent landscape for Achromycin V, and when can generic versions of Achromycin V launch?

Achromycin V is a drug marketed by Lederle and Heritage Pharma and is included in two NDAs.

The generic ingredient in ACHROMYCIN V is tetracycline hydrochloride. There are ninety-nine drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the tetracycline hydrochloride profile page.

Summary for Tradename: ACHROMYCIN V

Patents:0
Applicants:2
NDAs:2
Suppliers / Packagers: see list1
Bulk Api Vendors: see list29
Patent Applications: see list6,502
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:ACHROMYCIN V at DailyMed

Pharmacology for Tradename: ACHROMYCIN V

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Lederle
ACHROMYCIN V
tetracycline hydrochloride
SUSPENSION;ORAL050263-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Heritage Pharma
ACHROMYCIN V
tetracycline hydrochloride
CAPSULE;ORAL050278-003Approved Prior to Jan 1, 1982ABRXYesNo► Subscribe► Subscribe
Heritage Pharma
ACHROMYCIN V
tetracycline hydrochloride
CAPSULE;ORAL050278-001Approved Prior to Jan 1, 1982ABRXYesYes► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Chinese Patent Office
Julphar
Queensland Health
AstraZeneca
Novartis
QuintilesIMS
Cerilliant
US Army
Express Scripts
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot